Company profile for BlueSphere Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

BlueSphere Bio was founded to unlock the potential of personalized T cell therapy for the treatment of cancer by harnessing the unique specificity of each patient’s own T cells for the particular molecular fingerprint of each patient’s own cancer through our novel TCXpress technology. Our proprietary TCXpress platform is an elegant, rapid approach that exploits the patient’s own immune defenses to attack their cancer sp...
BlueSphere Bio was founded to unlock the potential of personalized T cell therapy for the treatment of cancer by harnessing the unique specificity of each patient’s own T cells for the particular molecular fingerprint of each patient’s own cancer through our novel TCXpress technology. Our proprietary TCXpress platform is an elegant, rapid approach that exploits the patient’s own immune defenses to attack their cancer specifically, and is designed to leave normal tissues untouched, thereby reducing harmful side effects.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
350 Technology Drive, Suite 520, Pittsburgh, PA 15219
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/05/16/3083200/0/en/BlueSphere-Bio-Appoints-Alan-Korman-Ph-D-as-Chief-Scientific-Officer.html

GLOBENEWSWIRE
16 May 2025

https://www.globenewswire.com/news-release/2024/08/14/2930211/0/en/BlueSphere-Bio-Accepted-as-Member-of-Johnson-Johnson-Innovation-JLABS.html

GLOBENEWSWIRE
14 Aug 2024

https://www.globenewswire.com/news-release/2024/06/25/2903924/0/en/BlueSphere-Bio-To-Partner-with-NMDP-BioTherapies-for-the-Company-s-First-In-Human-TCR-based-Product-Candidate-in-Combination-with-Allogeneic-Hematopoietic-Cell-Transplantation-Tria.html

GLOBENEWSWIRE
25 Jun 2024

https://www.globenewswire.com/news-release/2024/06/04/2893172/0/en/BlueSphere-Bio-Establishes-Strategic-Collaboration-with-the-National-Cancer-Institute-to-Advance-Treatments-for-Rare-Respiratory-Disease.html

GLOBENEWSWIRE
04 Jun 2024

https://www.globenewswire.com/news-release/2024/06/03/2892552/0/en/BlueSphere-Bio-Announces-IND-Clearance-of-its-First-in-Human-Candidate-and-New-Cell-Therapy-Portfolio-for-High-Risk-Leukemia-Patients.html

GLOBENEWSWIRE
03 Jun 2024

https://www.globenewswire.com/news-release/2024/05/30/2890893/0/en/BlueSphere-Bio-to-Present-Corporate-Update-and-Participate-in-a-Panel-Discussion-at-the-2024-BIO-International-Convention.html

GLOBENEWSWIRE
30 May 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty